Veröffentlichungen
Veröffentlichungen
2021
Gödde, K., Siegerink, B., Fügemann, H., Keune, D., Sander, S., Schneider, A., Müller-Nordhorn, J., Holmberg, C., Rieckmann, N., Frost, N., Keilholz, U., Goerling, U.
Can routine register data be used to identify vulnerable lung cancer patients of suboptimal care in a German comprehensive cancer centre?
2020
Czogalla, B., Pham, D., Trillsch, F., Rottmann, M., Gallwas, J., Burges, A., Mahner, S., Kirchner, T., Jeschke, U., Mayr, D. & Schmoeckel, E. (2020).
PD‑L1 expression and survival in p16‑negative and ‑positive squamous cell carcinomas of the vulva.
Ditsch, N., Heublein, S., Jeschke, U., Sattler, C., Kuhn, C., Hester, A., Czogalla, B., Trillsch, F., Mahner, S., Engel, J., Mayr, D. & Schmoeckel, E. (2020).
Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients.
Finke, I., Behrens, G., Schwettmann, L., Gerken, M., Pritzkuleit, R., Holleczek, B., Brenner, H., Jansen, L., & German Cancer Survival Working Group (2020).
Socioeconomic differences and lung cancer survival in Germany: Investigation based on population-based clinical cancer registration.
Gödde, K., Fügemann, H., Müller-Nordhorn, J., Grimberg, M., Goerling, U., Siegerink, B., Rieckmann, N., Holmberg, C.
Strukturierte Erfassung von Unterstützungsangeboten für Lungenkrebs- und Schlaganfallbetroffene in Berlin [Structured Collection of Data on Support Offers for Lung Cancer and Stroke Patients in Berlin].
Grundmann, N., Meisinger, C., Trepel, M., Müller-Nordhorn, J., Schenkirsch, G., Linseisen, J.
Trends in cancer incidence and survival in the Augsburg study region-results from the Augsburg cancer registry.
Han, N., Heublein, S., Jeschke, U., Kuhn, C., Hester, A., Czogalla, B., Mahner, S., Rottmann, M., Mayr, D., Schmoeckel, E. & Trillsch F. (2020)
Han, N., Jeschke, U., Kuhn, C., Hester, A., Czogalla, B., Mahner, S., Rottmann, M., Mayr, D., Schmoeckel, E., & Trillsch, F. (2020).
H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology.
Jansen, L., Behrens, G., Finke, I., Maier, W., Gerken, M., Pritzkuleit, R., Holleczek, B., Brenner, H., & German Cancer Survival Working Group (May 2020).
Area-Based Socioeconomic Inequalities in Colorectal Cancer Survival in Germany: Investigation Based on Population-Based Clinical Cancer Registration.
Papathemelis, T., Oppermann, H., Grafl, S., Gerken, M., Pauer, A., Scharl, S., Scharl, A., Inwald, E., Ignatov, A., Ortmann, O., Klinkhammer-Schalke, M., Hein, A., Beckmann, M. W. & Lux, M. P. (2020).
Long-term outcome of patients with intermediate- and high-risk endometrial cancer after pelvic and paraaortic lymph node dissection: a comparison of laparoscopic vs. Open procedure.
Prantl, L., Gerken, M., Zeman, F., Leitzmann, M., Koller, M., Klinkhammer-Schalke, M., Evert, M., Kuehlmann, B. & Biermann, N (2020).
Incidence of Anaplastic Large Cell Lymphoma and Breast-Implant-Associated Lymphoma—An Analysis of a Certified Tumor Registry over 17 Years.
Schultze, M., Müller-Nordhorn, J., Holmberg, C.
Discussing the effects of prostate cancer beyond biographical disruption and new normalcy: the experiences of men with prostate cancer in Germany.
Spanier, G., Böttcher, J., Gerken, M., Fischer, R., Roth, G., Lehn, P., Klingelhöffer, C., Meier, J. K., Fraccaroli, A., Tischer, J., Ettl, T., Klinkhammer-Schalke, M., Reichert, T. E. & Spoerl, S.
Prognostic value of perioperative red blood cell transfusion and anemia on survival and recurrence in oral squamous cell carcinoma.
Spoerl, S., Gerken, M., Mamilos, A., Fischer, R., Wolf, S., Nieberle, F., Klingelhöffer, C., Meier, J. K., Spoerl, S., Ettl, T., Reichert, T. E. & Spanier, G. (2020).
Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study.
Trillsch, F., Mahner, S., Czogalla, B., Rottmann, M., Chekerov, R., Braicu, E. I., Oskay-Öczelik, G., Wimberger, P., Richter, R. & Sehouli, J. (2020).
2019
Pölcher, M., Rottmann, M., Brugger, S., Mahner, S., Dannecker, C., Kiechle, M., Brambs, C., Grab, D., Anthuber, C., von Koch, F., Schnelzer, A. & Engel, J. (2019).
Lymph node dissection in endometrial cancer and clinical outcome: A population-based study in 5546 patients.
Radespiel-Tröger, M., Voigtländer, S., Meyer, M., Müller-Nordhorn, J., Behringer, J., Schöfl, C., & Hollederer, A. (2019).
Assoziation zwischen Häufigkeit der Sonographie und Prävalenz bösartiger Neubildungen der Schilddrüse bei Versicherten der AOK in Bayern.
Schmoeckel, E., Hofmann, S., Fromberger, D., Rottmann, M., Luthardt, B., Burges, A., Jeschke, U., Kirchner, T., Lax, S. F. & Mayr, D. (2019).
Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic facors in ovarian carcinoma.
2018
Blödt S, Kaiser M, Adam Y, Adami S, Schultze M, Müller-Nordhorn J, Holmberg C.
Understanding the role of health information in patients’ experiences: secondary analysis of qualitative narrative interviews with people diagnosed with cancer in Germany.
Corradini, S., Pazos, M., Schönecker, S., Reitz, D., Niyazi, M., Ganswindt, U., Schrodi, S., Braun, M., Pölcher, M., Mahner, S., Harbeck, N., Engel, J. & Belka, C. (2018).
Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases.
Heckl, M., Schmoeckel, E., Hertlein, L., Rottmann, M., Jeschke, U. & Mayr, D. (2018).
The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.
Weiss, M., Sim, D. A., Herold, T., Schumann, R. G., Liegl, R., Kern, C., Kreutzer, T., Schiefelbein, J., Rottmann, M., Priglinger, S. & Kortuem, K. U. (2018).
Compliance and Adherence of Patients with Diabetic Macular Edema to Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Daily Practice.
Würstlein, R., Hesse, A., König, A., Schulte-Vorwick, F., Schrodi, S., Ditsch, N., Mahner, S. & Harbeck, N. (2018).
Tastbefund an der Brust: Auch bei Männern immer abklären!
2017
Bastiaannet, E., Charman, J., Johannesen, T. B., Schrodi, S., Siesling, S., van Eycken, L., Walsh, P. M., Audisio, R. A., Boelens, P. G., Rubio, I. T., Jones, N., Lewis, J. & van de Velde, C. J. H.
A European, Observational Study of Endocrine Therapy Administration in Patients with an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer.
Engler J, Güthlin C, Dahlhaus A, Kojima E, Müller-Nordhorn J, Weißbach L, Holmberg C.
Physician cooperation in outpatient cancer care. An amplified secondary analysis of qualitative interview data.
Giesler JM, Keller B, Repke T, Leonhart R, Weis J, Muckelbauer R, Rieckmann N, Müller-Nordhorn J, Lucius-Hoene G, Holmberg C.
Effect of a Website That Presents Patients‘ Experiences on Self-Efficacy and Patient Competence of Colorectal Cancer Patients: Web-Based Randomized Controlled Trial.
Rottmann, M., Burges, A., Mahner, S., Anthuber, C., Beck, T., Grab, D., Schnelzer, A., Kiechle, M., Mayr, D., Pölcher, M., Schubert-Fritschle, G., & Engel J. (2017).
Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomes.
Schmoeckel, E., Odai-Afotey, A. A., Schleißheimer, M., Rottmann, M., Flesken-Nikitin, A., Ellenson, L. H., Kirchner, T., Mayr, D. & Nikitin, A. Y. (2017).
LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions.
Twardella, D., Geiss, K., Radespiel-Tröger, M., Benner, A., Ficker, J.H., & Meyer, M.
Trends der Lungenkrebsinzidenz nach histologischem Subtyp bei Männern und Frauen in Deutschland. Analyse von Krebsregisterdaten unter Einsatz von multipler Imputation.
2016
Engler J, Adami S, Adam Y, Keller B, Repke T, Fügemann H, Lucius-Hoene G, Müller-Nordhorn J, Holmberg C. (2016).
Using others‘ experiences. Cancer patients’ expectations and navigation of a website providing narratives on prostate, breast and colorectal cancer.
2015
Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Stabenow R, Froehner M, Huber J
Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer:
A comparison of treatment trends in the United States and Germany from 2004 to 2011
Keller AK, Uter W, Pfahlberg AB, Radespiel-Tröger M, Mayer I, Gefeller O.
Replacing surrogate measures by direct quantification of ultraviolet radiation exposure
in registry-based analyses of seasonality of melanoma diagnoses.
2014
Nennecke A, Geiss K, Hentschel S, Vettorazzi E, Jansen L, Eberle A, Holleczek B, Gondos A, Brenner H,
and the GEKID cancer survival working group
Survival of cancer patients in urban and rural areas of Germany - a comparison.
Radespiel-Tröger M, Batzler WU, Holleczek B, Luttmann S, Pritzkuleit R, Stabenow R, Urbschat I, Zeissig SR, Meyer M.
Im Namen der Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (GEKID)
Inzidenzzunahme des papillären Schilddrüsenkarzinoms in Deutschland
2013
Geiss K, Meyer M.
A Windows application for computing standardized mortality ratios and
standardized incidence ratios in cohort studies based on calculation of exact person-years at risk
Schrodi S, Braisch U, Schenkirsch G, Maisel T, Petsch S, Hölzel D, Klinkhammer-Schalke M,
Mäder U, Schuller L, Heywang-Köbrunner SH, Meyer M, Engel J.
Veränderungen der Therapie des Mammakarzinoms in Bayern seit Einführung des Mammografie-Screenings.
Eine Analyse bayerischer Krebsregisterdaten der Jahre 2000 bis 2008
2012
Braisch U, Geiss K, Radespiel-Tröger M, Meyer M.
Population-Based Effects of Mammography Screening in Bavaria on the Distribution of TNM-T Categories
with Respect to Different Histological Subgroups
Braisch U, Meyer M, Radespiel-Tröger M.
Risk of subsequent primary cancer among prostate cancer patients in Bavaria, Germany.
Braisch U, Meyer M, Radespiel-Tröger M
Risk of tobacco-related multiple primary cancers in Bavaria, Germany
Kuznetsov L, Maier W, Hunger M, Meyer M, Mielck A.
Regional deprivation in Bavaria, Germany:
linking a new deprivation score with registry data for lung and colorectal cancer .
Nennecke A, Barnes B, Brenner H, Eberle A, Emrich K, Eisemann N, Geiss K, Hentschel S, Holleczek B, Kraywinkel K, Stabenow R, Hense HW.
Datenqualität oder Unterschiede in der onkologischen Versorgung?
- Berichtsstandards für Überlebenszeitanalysen mit Krebsregisterdaten
Radespiel-Tröger M, Meyer M.
Association between drinking water uranium content and cancer risk in Bavaria, Germany
Radespiel-Tröger M, Meyer M, Fenner M.
Geographic differences and time trends of intraoral cancer incidence and mortality in Bavaria, Germany.
2011
Kuznetsov L, Maier W, Hunger M, Meyer M, Mielck A.
Associations between regional socioeconomic deprivation and cancer risk:
Analysis of population-based Cancer Registry data from Bavaria, Germany.
Radespiel-Tröger, M.
Radespiel-Tröger M:
2010
Katalinic A, Emrich K,Luttmann S, Holleczek B, Stabenow R, Urbschat I, Meyer M:
Nennecke A, Brenner H, Eberle A, Geiss K, Holleczek B, Kieschke J, Kraywinkel K,
GEKID-Arbeitsgruppe "Überlebenszeitanalyse":
Überlebenschancen von Krebspatienten in Deutschland - auf dem Weg zu repräsentativen, vergleichbaren Aussagen
2009
Geiss K, Meyer M, Radespiel-Tröger M, Gefeller O.:
SURVSOFT-Software for nonparametric survival analysis.
Meyer M, Opitz T, Caselmann WH, Schenkirsch G, Maisel T, Petsch S, Engel J,
Radespiel-Tröger M, Meyer M, Pfahlberg A, Lausen B, Gefeller O:
Outdoor work and skin cancer incidence: a registry based study in Bavaria.
Staykov D, Radespiel-Tröger M, Meyer M, Petsch S, Schwab S and Handschu R:
Birth Month and Risk of Glioma in Adults: A Registry-Based Study in Bavaria.
2008
2006
Meyer M, Gärtig-Daugs A, Radespiel-Tröger M:
Mobilfunkbasisstationen und Krebshäufigkeit in Bayern
Meyer M, Gärtig-Daugs A, Radespiel-Tröger M:
Vorträge und Poster
2011
Geiss K, Braisch U, Schrodi S, Schenkirsch G, Maisel T, Petsch S, Klinkhammer-Schalke M, Mäder U, Hölzel D, Heywang-Köbrunner, Engel J, Meyer M
Meyer M:
Automatisches Best-of - Datenbankimplementierung des Lokalisationsbaums .Vortrag
bei der 19. Informationstagung Tumordokumentation der klinischen und epidemiologischen Krebsregister,
Bayreuth, 30.3.2011
2005
Meyer M, Gärtig-Daugs A, Radespiel-Tröger M:Krebsinzidenz im Umkreis von Mobilfunkbasisstationen (PDF-Datei 300 kB)
2004
Daugs A:
Epidemiologische Grundbegriffe (PDF-Datei 215 kB)
Gärtig-Daugs A, Radespiel-Tröger M, Meyer M:
Simulationsmodell zur Unterstützung der Risikokommunikation in der Krebsepidemiologie (PDF-Datei 794 kB)
Meyer M, Radespiel-Tröger M, Petsch S, Schick S, Friedrich M:
Epidemiologische Krebsregistrierung: Maßnahmen zur Erreichung einer hohen Datenqualität (PDF-Datei 570 kB)
Radespiel-Tröger M, Daugs A, Meyer M:
Simulation model for visualisation of small-area cancer incidence rates (PDF-Datei 1013 kB)
2003
2000
